Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Registration
    • Conference Registration
    • Exhibitor Registration
    • Hotel Reservations
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • App View

Synthesis and Characterization of Novel Sulfanilamides as Potential Chemotherapeutic Agents

Undergraduate #34
Discipline: Chemistry and Chemical Sciences
Subcategory: Chemistry (not Biochemistry)

Sekou Stuppard - Howard University
Co-Author(s): Rebecca Bernadel, Howard University, Washington, DC



Sulfonamides were heavily utilized during World War I and II to treat infections due to their antibacterial properties. In the following decades, more effective sulfanilamides were created to treat bacterial infections. Today these compounds are used to assist patients who battle infections that are immune to standard antibiotics. In general, sulphonamides are referred to as sulfa drugs due to the presence of the sulfonamide group. They have been clinically attractive synthetic antibiotics for the past half-century for treatment of systemic infections. We aim to design novel chemotherapeutically active agents derived from isatin (sulfanilamide derivative). This was achieved through the alkylation reaction of isatin (ISA), 4-(2-oxoindolin-3-ylideneamino)benzenesulfonamide, with various alcohols in a 1:1 molar ratio in the presence of catalytic amounts of calcium carbonate and copper acetate as catalysts. The desired alkylated sulfanilamides were characterized based on melting points, elemental analyses, FT-IR and 1H- and cosy NMR. The IR analysis confirmed that new products have been achieved. The narrow melting point and 1H NMR spectrum indicate that the product obtained in pure form. Further characterization will be completed and then these new sulfa compounds will be screened as potential anticancer and antitumor agents for multidrug resistant cancer cells.

Funder Acknowledgement(s): National Science Foundation; Howard University Global Education Awareness and Research Undergraduate Program (HU GEAR UP)

Faculty Advisor: Salam Titinchi, stitinchi@gmail.com

Role: My co-author and I both synthesized the sulfanilamides and characterized them through various analyses.

ERN Conference

Celebrating 10 years of ERN!

What’s New

  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • #ShutDownSTEM
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

Navigation

  • About the ERN Conference
  • Partners/Supporters
  • Abstracts
  • Travel Awards
  • Conference Registration
  • Exhibitor Registration
  • Hotel Reservations

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2021 American Association for the Advancement of Science